Results
76,369 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | McCurry Jennifer LynnChief Accounting Officer |  LZBLA-Z-BOY INCTax withholding | F | $10K 253 sh | Jun 29, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | McCurry Jennifer LynnChief Accounting Officer | LZBLA-Z-BOY INC Tax withholding | F | $10K 253 sh | Jun 29, 2026 |
| 5 | Shah Aarti S.Director |  NVDANVIDIA CORPGrant or award | A | — 1,211 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Goodrich KatherineDirector |  TARSTarsus Pharmaceuticals, Inc.Grant or award | A | — 3,837 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Giroux RichardCFO & COO |  MGTXMeiraGTx Holdings plcGrant or award | A | — 980.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Jimenez Freddy A.SVP & GENERAL COUNSEL |  CLDXCelldex Therapeutics, Inc.Grant or award | A | — 93.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 5 | Leggett Michael AdamSr VP & Chief Supply Chain Off | LZBLA-Z-BOY INC Tax withholding | F | $15K 365 sh | Jun 29, 2026 traded Jun 28, 2026 |
| 4 | Dhanasekaran SatishDirector, President and CEO |  KEYSKeysight Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $183K 507 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 4 | Kumaraswami RaviPres. Worldwide Field Ops. |  RSKDRISKIFIED LTD.Open-market sale · 10b5-1 plan | SELL | $167K 33.4K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 4 | Camblong JurgiDirector, Chief Executive Officer |  SOPHSOPHiA GENETICS SAOption exercise · 10b5-1 plan | M | — 31.9K sh | Jun 29, 2026 traded Jun 26, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER |  GPCRStructure Therapeutics Inc.Derivative conversion · 10b5-1 plan | C | — 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lechleider RobertChief Medical Officer |  IMNMImmunome Inc.Option exercise · 10b5-1 plan | M | — 55.0K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 3 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | $8,036 23.6K sh | Jun 29, 2026 traded Jun 25, 2026 |
| 2 | Abrahamsen Danielle NicoleChief Accounting Officer |  CVLTCOMMVAULT SYSTEMS INCGrant or award | A | — 244 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 1 | Rosenberg NickExecutive Vice President |  MCBMetropolitan Bank Holding Corp.Open-market sale · 10b5-1 plan | SELL | $9,005 90 sh | Jun 29, 2026 traded Jun 29, 2026 |
| 1 | Kumaraswami RaviPres. Worldwide Field Ops. | RSKDRISKIFIED LTD. Open-market sale · 10b5-1 plan | SELL | $500 100 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 1 | Rosenberg NickExecutive Vice President | MCBMetropolitan Bank Holding Corp. Open-market sale · 10b5-1 plan | SELL | $26K 263 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | D'Amico AndrewDirector |  VICRVICOR CORPOption exercise · 10b5-1 plan | M | — 331 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $20K 331 sh | Jun 29, 2026 traded Jun 26, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary | VICRVICOR CORP Option exercise · 10b5-1 plan | M | — 1,000 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Derivative conversion · 10b5-1 plan | C | — 7,878 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $100K 1,000 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | — 200 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | D'Amico AndrewDirector | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $20K 200 sh | Jun 29, 2026 traded Jun 25, 2026 |
| 0 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $101K 31.9K sh | Jun 29, 2026 traded Jun 26, 2026 |
| 50 | Calamos Aksia Hedged Strategies Fund (Offshore), Ltd.10% Owner | NACalamos Aksia Hedged Strategies Fund Open-market purchase | BUY | $405K 39.0K sh | Jun 26, 2026 traded Apr 27, 2026 |
| 49 | Swets Larry G JrDirector |  GLNDGreenland Energy CoOpen-market purchase | BUY | $30K 25.0K sh | Jun 26, 2026 traded May 12, 2026 |
| 48 | Ho EmilyChief Accounting Officer |  SNOWSnowflake Inc.Open-market sale | SELL | $432K 1,860 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 45 | Employees' Retirement System of the State of Hawaii10% Owner | NALafayette Square USA, Inc. Open-market purchase | BUY | $20.00M 1.37M sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Gloria MelanieChief Operating Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $563K 14.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Van Tuyl ChristopherChief Legal Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $572K 15.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 42 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $1.27M 33.3K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 39 | McCurry Jennifer LynnChief Accounting Officer | LZBLA-Z-BOY INC Open-market sale | SELL | $153K 3,715 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 38 | Girao TiagoChief Financial Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $385K 10.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 36 | Marchington AndrewChief Financial Officer |  GRUSFGrown Rogue International Inc.Open-market sale | SELL | $602 1,400 sh | Jun 26, 2026 traded Apr 22, 2026 |
| 35 | Smolyansky Edward10% Owner |  LWAYLifeway Foods, Inc.Open-market sale | SELL | $1.09M 36.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 35 | Smolyansky LudmilaMember of 10% owner group | LWAYLifeway Foods, Inc. Open-market sale | SELL | $1.20M 40.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 35 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $262K 6,723 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 35 | Gloria MelanieChief Operating Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $116K 2,966 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 35 |  Cleo FieldsDSelf |  GOOGAlphabet Inc.Purchase | BUY | $1,001 – $15K | Jun 26, 2026 traded Jun 15, 2026 |